Monday, April 29, 2019

Glenmark launches novel, anti-diabetes drug Remogliflozin in India

SGLT2 drugs provide glycemic control, induce weight loss and reduce cardiovascular risks.

from India Infoline News Service http://bit.ly/2PE6R1o
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)